akobytbohatymmdea.firebaseapp.com

Sek forma s-1mef

7963

Jan 07, 2021 · S-1MEF KemPharm ® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

S-1MEF Filing Date. June 18, 2020. Form Description. Registration of up to an additional 20% of securities for any offering registered on an S-1. Filing Group. Form. S-1MEF Filing Date.

  1. Ako nájdem svoj paypal odkaz
  2. Obchodovanie s bitcoinmi zadarmo
  3. Ako kúpiť xlm na webull
  4. T kurzívou
  5. Bitcoinové budúce zmluvy
  6. Vinny lingham čisté imanie

Registration of up to an additional 20% of securities for any offering registered on an S-1. Initial Public Offering (IPO): Registration of Additional Securities — Form S-1 Filing Table of Contents Document/Exhibit Description Pages Size 1: S-1MEF S-1 Filed Pursuant to Rule 462(B) HTML 33K 2: EX-5.1 Opinion of Cooley Godward LLP HTML 11K 3: EX-23.1 Consent of Ernst & Young LLP HTML 6K Represents only the additional amount of securities being registered. The registrant previously registered securities at an aggregate offering price not to exceed $8,050,000.00 on a Registration Statement on Form S-1 (File No. 333-252275), which was declared effective by the Securities and Exchange Commission on February 8, 2021. The Company hereby incorporates by reference into this Registration Statement on Form S-1 in its entirety the Registration Statement on Form S-1 (File No. 333-236298), as amended (including the exhibits thereto), declared effective on June 2, 2020 by the U.S. Securities and Exchange Commission (the “Commission”). The registrant previously registered securities with a proposed maximum aggregate offering price not to exceed $2,547,756,000 on the Registration Statement on Form S-1, as amended (File No. 333-229996), which was declared effective by the Securities and Exchange Commission on March 28, 2019.

The Registrant previously registered securities with an aggregate offering price not to exceed $91,640,625 on a Registration Statement on Form S-1, as amended (File No. 333-248611), which was declared effective by the Securities and Exchange Commission on September 24, 2020. In accordance with Rule 462(b) under the Securities Act, an additional

Sek forma s-1mef

Dec 10, 2020. Dec 10, 2020. Form Description. Registration of up to an additional 20% of securities for any offering registered on an S-1 As filed with the U.S. Securities and Exchange Commission on December 23, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VIVEON HEALTH ACQUISITION CORP.

SEC Filing Details. SEC Filing Details. Document Details. Form. S-1MEF Filing Date. Apr 2, 2020. Document Date. Apr 2, 2020. Form Description. Registration of up to an additional 20% of securities for any offering registered on an S-1. Filing Group. Registration Statements.

Sek forma s-1mef

Washington, D.C. 20549 . FORM S-1. REGISTRATION STATEMENT . Under . The Securities Act of 1933 . Forma Therapeutics Holdings, Inc. (Exact name of registrant as specified in its charter) Dec 03, 2020 · Form. S-1MEF Filing Date.

2 days ago · Form S-1MEF Coupang, Inc. (File No. 333-253030), which was declared effective by the Securities and Exchange Commission on March 10, 2021. In accordance with Rule 462(b) under the Securities Jan 07, 2021 · S-1MEF KemPharm ® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products. S-1MEF.

Form Description. Registration of up to an additional 20% of securities for any offering registered on an S-1. Filing Group. Registration Statements. The registrant previously registered securities at an aggregate offering price not to exceed $180,837,500 on a Registration Statement on Form S-1 (File No. 333-233985), which was declared effective by the Securities and Exchange Commission on February 5, 2020.

Sep 10, 2020. Document Date. Sep 10, 2020. Form Description May 27, 2015 · Form. S-1MEF Filing Date. May 27, 2015. May 27, 2015.

Filings . S-1MEF 1 d596145ds1mef.htm FORM S-1MEF As filed with the Securities and Exchange Commission on September 20, 2018. Registration No. 333- UNITED STATES Dec 10, 2020 · S-1MEF Filing Date. Dec 10, 2020. Dec 10, 2020.

FORM S-1. REGISTRATION STATEMENT . We refer to the Registration Statement on Form S-1 filed by Outset Medical, Inc., a Delaware corporation (the “ Company ”), with the Securities and Exchange Commission (the “ SEC ”) on the date hereof pursuant to Rule 462 (b) (the “ Additional Registration Statement ”) under the Securities Act of 1933, as amended (the “ Securities Act ”). Represents only the additional amount of securities being registered.

mobilná aplikácia circle k
3 000 eur za usd
aký bagel v mojej blízkosti
trh bittrex.com
mozes financovat laptop na amazone
kurz blockchainu a kryptomeny zadarmo
400 eur na britské libry

S-1MEF KemPharm ® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Registration No. 333- UNITED STATES Dec 10, 2020 · S-1MEF Filing Date. Dec 10, 2020. Dec 10, 2020.